Guru Ownership Trend
Guru Analysis for Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. (CRDF), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $342,077.27.
Top institutional holders include Cliff Asness and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $287,651.19 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 423.5%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 86.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Cardiff Oncology, Inc. (CRDF)
Major holders include Cliff Asness ($450,260), Steven Cohen ($36,901), Renaissance Technologies (RenTech) ($18,125). According to the latest reported data, 3 tracked investment managers collectively hold approximately 388,680 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $287,651.19, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CRDF. The total reported sell value was $113,506.8.
Yes, 1 managers opened new positions in CRDF, and 1 increased their existing holdings. The total reported buy value was $401,157.99.